難治性の肝・胆道疾患に関する調査研究 厚生労働省難治性疾患政策研究事業

研究の成果

肝移植

最終更新日:2022年6月2日
  1. Akamatsu N, Hasegawa K, Egawa H, Ohdan H, Yoshizawa A, Kokudo N, Tazuma S, Tanaka A, Takikawa H. Donor age (≥45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation - a multicenter retrospective study. Transpl Int. 2021 May;34(5):916-929. doi: 10.1111/tri.13852. Epub 2021 Mar 16. PMID: 33629379. https://pubmed.ncbi.nlm.nih.gov/33629379/
  2. Watanabe T, Nakai Y, Mizuno S, Hamada T, Kogure H, Hirano K, Akamatsu N, Hasegawa K, Isayama H, Koike K. Prognosis of primary sclerosing cholangitis according to age of onset. J Hepatobiliary Pancreat Sci. 2021 Dec;28(12):1115-1120. doi: 10.1002/jhbp.952. Epub 2021 Apr 15. PMID: 33811469. https://pubmed.ncbi.nlm.nih.gov/33811469/
このページの先頭へ